Unknown German company

BioNTech SE is a German biotechnology company that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. The company is globally recognized for its pioneering work in messenger RNA (mRNA) technology, which led to the development of the first authorized mRNA-based vaccine for COVID-19 in partnership with Pfizer. Beyond infectious diseases, BioNTech is advancing a diverse pipeline of oncology candidates, including individualized neoantigen therapies, CAR-T cell therapies, and novel antibodies. Headquartered in Mainz, Germany, BioNTech aims to harness the full potential of the immune system to treat cancer, infectious diseases, and other serious conditions. The company is publicly traded on the NASDAQ under the symbol BNTX.